Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| 1 |
Apple
AAPL
|
+$1.37B |
| 2 |
Schwab Intermediately-Term US Treasury ETF
SCHR
|
+$1.24B |
| 3 |
Chevron
CVX
|
+$472M |
| 4 |
Pfizer
PFE
|
+$372M |
| 5 |
Amazon
AMZN
|
+$369M |
Top Sells
| 1 |
Schwab US Large- Cap ETF
SCHX
|
+$9.58B |
| 2 |
Schwab 5-10 Year Corporate Bond ETF
SCHI
|
+$5.28B |
| 3 |
Schwab International Equity ETF
SCHF
|
+$4.53B |
| 4 |
Schwab U.S Small- Cap ETF
SCHA
|
+$4.13B |
| 5 |
Schwab Emerging Markets Equity ETF
SCHE
|
+$2.63B |
Sector Composition
| 1 | Technology | 22.61% |
| 2 | Financials | 12.09% |
| 3 | Healthcare | 10.58% |
| 4 | Consumer Discretionary | 9.24% |
| 5 | Industrials | 8.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2601
National Research Corp
NRC
$374M
| $2.83M | ﹤0.01% |
123,741
+7,866
| +7% | +$180K |
|
2602
Build-A-Bear
BBW
$985M
| $2.82M | ﹤0.01% |
82,167
-12,075
| -13% | -$415K |
|
|
FSUN
2603
FirstSun Capital Bancorp Common Stock
FSUN
$1.07B
| $2.82M | ﹤0.01% |
+66,102
| New | +$2.82M |
|
2604
Vanda Pharmaceuticals
VNDA
$272M
| $2.8M | ﹤0.01% |
596,210
+3,473
| +0.6% | +$16.3K |
|
|
VERV
2605
DELISTED
Verve Therapeutics
VERV
| $2.77M | ﹤0.01% |
572,173
+126,110
| +28% | +$610K |
|
2606
C4 Therapeutics
CCCC
$194M
| $2.75M | ﹤0.01% |
482,929
-6,029
| -1% | -$34.4K |
|
2607
Lindblad Expeditions
LIND
$752M
| $2.74M | ﹤0.01% |
295,786
+3,087
| +1% | +$28.6K |
|
2608
Global E Online
GLBE
$6.22B
| $2.74M | ﹤0.01% |
71,151
+6,485
| +10% | +$249K |
|
2609
8x8 Inc
EGHT
$303M
| $2.73M | ﹤0.01% |
1,338,701
+23,731
| +2% | +$48.4K |
|
2610
Sapiens International
SPNS
$2.4B
| $2.73M | ﹤0.01% |
73,222
-67
| -0.1% | -$2.5K |
|
2611
Vivid Seats
SEAT
$112M
| $2.72M | ﹤0.01% |
36,795
+9,728
| +36% | +$720K |
|
2612
Organogenesis Holdings
ORGO
$639M
| $2.71M | ﹤0.01% |
948,451
+23,675
| +3% | +$67.7K |
|
2613
El Pollo Loco
LOCO
$313M
| $2.7M | ﹤0.01% |
196,817
-8,120
| -4% | -$111K |
|
2614
Montauk Renewables
MNTK
$299M
| $2.69M | ﹤0.01% |
516,724
+1,253
| +0.2% | +$6.53K |
|
2615
Luminar Technologies
LAZR
$122M
| $2.69M | ﹤0.01% |
199,427
+28,355
| +17% | +$383K |
|
2616
Fate Therapeutics
FATE
$118M
| $2.67M | ﹤0.01% |
763,808
-115,567
| -13% | -$404K |
|
2617
Absci
ABSI
$410M
| $2.67M | ﹤0.01% |
697,849
+11,602
| +2% | +$44.3K |
|
2618
Corsair Gaming
CRSR
$965M
| $2.66M | ﹤0.01% |
382,734
-7,014
| -2% | -$48.8K |
|
2619
Takeda Pharmaceutical
TAK
$48.4B
| $2.66M | ﹤0.01% |
187,165
+27,628
| +17% | +$393K |
|
2620
Arm
ARM
$164B
| $2.64M | ﹤0.01% |
18,457
+8,707
| +89% | +$1.25M |
|
|
ONL
2621
Orion Office REIT
ONL
$166M
| $2.62M | ﹤0.01% |
656,047
-58,246
| -8% | -$233K |
|
2622
Hyliion Holdings
HYLN
$286M
| $2.62M | ﹤0.01% |
1,057,394
+20,541
| +2% | +$50.9K |
|
2623
SmartRent
SMRT
$280M
| $2.62M | ﹤0.01% |
1,515,124
+27,662
| +2% | +$47.9K |
|
2624
Qiagen
QGEN
$9.99B
| $2.62M | ﹤0.01% |
55,915
+1,792
| +3% | +$84K |
|
2625
Playtika
PLTK
$1.38B
| $2.61M | ﹤0.01% |
329,730
-77,216
| -19% | -$612K |
|